No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Medical - Devices
Medartis Holding AG is a global medical technology firm that develops, manufactures, and distributes implantable solutions. These advanced medical devices are utilized worldwide for the surgical stabilization of bone fractures in both the upper and lower extremities, in addition to addressing complex cranio-maxillofacial surgical needs. The company's portfolio features osteosynthesis instruments, marketed under the APTUS and MODUS brands, specifically designed for various body regions including the hand, wrist, elbow, shoulder, foot, and ankle, as well as for facial and skull procedures involving the mandible, midface, orthognathic structures, and cranium. Medartis serves a diverse clientele comprising surgeons, hospitals, medical centers, and group purchasing organizations. The company, founded in 1997, is headquartered in Basel, Switzerland.
www.medartis.comNo one on the platform currently holds MED.SW.
No tracked institution reports a position in MED.SW as of their last filing.
No one on the platform has traded MED.SW yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Consensus does not cover every selected forecast year. Later assumptions are extrapolated from available analyst estimates.
| Metric | Historical average | My assumptions | ||||
|---|---|---|---|---|---|---|
| 1 year | 5 years | 10 years | Low | Mid | High | |
| ROIC % | 0.3% | — | — | — | ||
| Rev. Growth % | 19.8% | 16.1% | ||||
| Profit Margin % | 3.1% | 1.2% | 1.5% | |||
| Free Cash Flow Margin % | 3.5% | 1.9% | -0.1% | |||
| Exit P/E | — | — | — | |||
| Exit P/FCF | — | — | — | |||
| Desired Annual Return % | — | — | — | |||
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $334M | +24.8% | $1.43 | $1.33–$1.50 | — | 3 |
| 2027 | $390M | +16.9% | $2.26 | $2.15–$2.53 | — | 4 |
| 2028 | $455M | +16.6% | $3.24 | $2.89–$3.63 | — | 4 |
| 2029 | $546M | +20.0% | $4.48 | $4.26–$4.66 | — | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| MED.SWMedartis Holding AG | $83.90 | +0.60% | $1.0B | — |
| AEVS.SWAevis Victoria S.A. | $12.70 | +0.40% | $1.1B | — |
| BSLN.SWBasilea Pharmaceutica AG | $66.10 | -0.90% | $818M | — |
| CLTN.SWCOLTENE Holding AG | $45.65 | -0.33% | $273M | — |
| COPN.SWCosmo Pharmaceuticals N.V. | $58.70 | +0.00% | $1.0B | — |
| DOCM.SWDocMorris AG | $9.77 | -2.30% | $478M |
Source: Financial Modeling Prep · peers by sector/industry
| — |
| IDIA.SWIdorsia Ltd | $5.00 | -0.04% | $1.3B | — |